These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 9157133)

  • 21. Recovery of Burkholderia cenocepacia strain PHDC from cystic fibrosis patients in Europe.
    Coenye T; Spilker T; Van Schoor A; LiPuma JJ; Vandamme P
    Thorax; 2004 Nov; 59(11):952-4. PubMed ID: 15516470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Widespread clone of Burkholderia cenocepacia in cystic fibrosis patients in the Czech Republic.
    Drevinek P; Vosahlikova S; Cinek O; Vavrova V; Bartosova J; Pohunek P; Mahenthiralingam E
    J Med Microbiol; 2005 Jul; 54(Pt 7):655-659. PubMed ID: 15947430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification, molecular characterisation and antimicrobial susceptibility of genomovars of the Burkholderia cepacia complex in Spain.
    Medina-Pascual MJ; Valdezate S; Villalón P; Garrido N; Rubio V; Saéz-Nieto JA
    Eur J Clin Microbiol Infect Dis; 2012 Dec; 31(12):3385-96. PubMed ID: 22855365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endemicity and inter-city spread of Burkholderia cepacia genomovar III in cystic fibrosis.
    Chen JS; Witzmann KA; Spilker T; Fink RJ; LiPuma JJ
    J Pediatr; 2001 Nov; 139(5):643-9. PubMed ID: 11713440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Burkholderia ambifaria sp. nov., a novel member of the Burkholderia cepacia complex including biocontrol and cystic fibrosis-related isolates.
    Coenye T; Mahenthiralingam E; Henry D; LiPuma JJ; Laevens S; Gillis M; Speert DP; Vandamme P
    Int J Syst Evol Microbiol; 2001 Jul; 51(Pt 4):1481-1490. PubMed ID: 11491349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Burkholderia cepacia genomovar VI, a new member of the Burkholderia cepacia complex isolated from cystic fibrosis patients.
    Coenye T; LiPuma JJ; Henry D; Hoste B; Vandemeulebroecke K; Gillis M; Speert DP; Vandamme P
    Int J Syst Evol Microbiol; 2001 Mar; 51(Pt 2):271-9. PubMed ID: 11321071
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of Burkholderia species, including members of Burkholderia cepacia complex, among UK cystic and non-cystic fibrosis patients.
    Kenna DTD; Lilley D; Coward A; Martin K; Perry C; Pike R; Hill R; Turton JF
    J Med Microbiol; 2017 Apr; 66(4):490-501. PubMed ID: 28463663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Burkholderia cepacia complex in cystic fibrosis: frequency of strain replacement during chronic infection.
    Bernhardt SA; Spilker T; Coffey T; LiPuma JJ
    Clin Infect Dis; 2003 Sep; 37(6):780-5. PubMed ID: 12955638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland.
    Pitt TL; Kaufmann ME; Patel PS; Benge LC; Gaskin S; Livermore DM
    J Med Microbiol; 1996 Mar; 44(3):203-10. PubMed ID: 8636938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomovar diversity amongst Burkholderia cepacia complex isolates from an Australian adult cystic fibrosis unit.
    Kidd TJ; Bell SC; Coulter C
    Eur J Clin Microbiol Infect Dis; 2003 Jul; 22(7):434-7. PubMed ID: 12884074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conservation of the opcL gene encoding the peptidoglycan-associated outer-membrane lipoprotein among representatives of the Burkholderia cepacia complex.
    Plesa M; Kholti A; Vermis K; Vandamme P; Panagea S; Winstanley C; Cornelis P
    J Med Microbiol; 2004 May; 53(Pt 5):389-398. PubMed ID: 15096547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans.
    Mahenthiralingam E; Vandamme P; Campbell ME; Henry DA; Gravelle AM; Wong LT; Davidson AG; Wilcox PG; Nakielna B; Speert DP
    Clin Infect Dis; 2001 Nov; 33(9):1469-75. PubMed ID: 11588691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular typing of, and distribution of genetic markers among, Burkholderia cepacia complex isolates from Brazil.
    Detsika MG; Corkill JE; Magalhães M; Glendinning KJ; Hart CA; Winstanley C
    J Clin Microbiol; 2003 Sep; 41(9):4148-53. PubMed ID: 12958239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a multiple-locus variable-number tandem-repeat typing scheme for genetic fingerprinting of Burkholderia cenocepacia and application to nationwide epidemiological analysis.
    Segonds C; Thouverez M; Barthe A; Bossuet-Greif N; Tisseyre L; Plésiat P; Vergnaud G; Chabanon G; Pourcel C
    J Clin Microbiol; 2015 Feb; 53(2):398-409. PubMed ID: 25411181
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Burkholderia cepacia complex: distribution of genomovars among isolates from the maize rhizosphere in Italy.
    Fiore A; Laevens S; Bevivino A; Dalmastri C; Tabacchioni S; Vandamme P; Chiarini L
    Environ Microbiol; 2001 Feb; 3(2):137-43. PubMed ID: 11321544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular epidemiology and antibiotic susceptibility of Burkholderia cepacia-complex isolates from an Italian cystic fibrosis centre.
    Golini G; Cazzola G; Fontana R
    Eur J Clin Microbiol Infect Dis; 2006 Mar; 25(3):175-80. PubMed ID: 16501927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular epidemiological investigation using a randomly amplified polymorphic DNA assay of Burkholderia cepacia isolates from nosocomial outbreaks.
    Okazaki M; Watanabe T; Morita K; Higurashi Y; Araki K; Shukuya N; Baba S; Watanabe N; Egami T; Furuya N; Kanamori M; Shimazaki S; Uchimura H
    J Clin Microbiol; 1999 Dec; 37(12):3809-14. PubMed ID: 10565889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of cable pili expression by cblA-containing Burkholderia cepacia complex.
    Sajjan U; Liu L; Lu A; Spilker T; Forstner J; LiPuma JJ
    Microbiology (Reading); 2002 Nov; 148(Pt 11):3477-3484. PubMed ID: 12427939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Burkholderia cenocepacia, B. multivorans, B. ambifaria and B. vietnamiensis isolates from cystic fibrosis patients have different profiles of exoenzyme production.
    Carvalho AP; Ventura GM; Pereira CB; Leão RS; Folescu TW; Higa L; Teixeira LM; Plotkowski MC; Merquior VL; Albano RM; Marques EA
    APMIS; 2007 Apr; 115(4):311-8. PubMed ID: 17504297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Burkholderia (Pseudomonas) cepacia epidemiology in a cystic fibrosis population: a genome finger-printing study.
    Cazzola G; Amalfitano G; Tonolli E; Perazzoli C; Piacentini I; Mastella G
    Acta Paediatr; 1996 May; 85(5):554-7. PubMed ID: 8827098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.